BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 2019
View Archived Issues
New model explains neural basis of alternating bilateral sensory stimulation for fear disorders
Read More
Stress hormones help metastasis along
Read More
How the other half controls appetite
Read More
Clotting protein cuts neuromuscular synapses, if it can
Read More
SunRegen Healthcare presents data on SRG-003 in monkeys with optic atrophy
Read More
Preclinical PK/PD studies help determine first-in-human dose of RG-7827
Read More
JP-1366 demonstrates safety and favorable PK in healthy subjects
Read More
FDA approves sNDA for Avycaz for pediatric patients with cUTI and cIAI
Read More
FDA clears Zenith Epigenetics' IND application for ZEN-3694 in TNBC program
Read More
Idorsia patents antibacterial pyrroloimidazolones
Read More
Novartis patent describes compounds for cancer
Read More
Asceneuron discloses OGA inhibitors
Read More
Sprint Bioscience synthesizes PIK3C3 inhibitors
Read More
TIME-2b study of AKB-9778 in diabetic retinopathy does not meet primary endpoint
Read More
ACADIA Pharmaceuticals presents 5-HT2A receptor ligands
Read More
Pascal Biosciences and Mitacs partner to support cancer research project at UBC
Read More
FDA approves Tecentriq with chemotherapy for first-line treatment of extensive-stage SCLC
Read More
Clinical data reported for litoxetine in mixed urinary incontinence
Read More
First subject dosed in phase II study of GRF-6019 in patients with severe Alzheimer's disease
Read More
Nicox opens phase II trial of NCX-4251 in blepharitis
Read More
NAMPT might predict docetaxel resistance in prostate cancer
Read More
First-in-human results for miltuximab described, theranostic trial of 89Zr/177Lu-miltuximab planned
Read More
Emergent BioSolutions initiates phase III study of anthrax vaccine AV-7909
Read More
Moleculin Biotech enrolls first patients in European trial of WP-1220 for CTCL
Read More
Crinetics initiates phase II program for CRN-00808 in acromegaly
Read More
